A detailed history of Oppenheimer Asset Management Inc. transactions in Amgen Inc stock. As of the latest transaction made, Oppenheimer Asset Management Inc. holds 5,857 shares of AMGN stock, worth $1.88 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
5,857
Previous 13,021 55.02%
Holding current value
$1.88 Million
Previous $3.7 Million 50.57%
% of portfolio
0.02%
Previous 0.06%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$262.75 - $319.31 $1.88 Million - $2.29 Million
-7,164 Reduced 55.02%
5,857 $1.83 Million
Q1 2024

May 06, 2024

SELL
$268.87 - $324.56 $436,107 - $526,436
-1,622 Reduced 11.08%
13,021 $3.7 Million
Q4 2023

Feb 13, 2024

SELL
$255.7 - $288.46 $495,290 - $558,747
-1,937 Reduced 11.68%
14,643 $4.22 Million
Q3 2023

Nov 07, 2023

BUY
$218.65 - $271.46 $72,591 - $90,124
332 Added 2.04%
16,580 $4.46 Million
Q2 2023

Aug 02, 2023

SELL
$214.27 - $253.37 $19,070 - $22,549
-89 Reduced 0.54%
16,248 $3.61 Million
Q1 2023

May 10, 2023

BUY
$225.79 - $275.2 $221,499 - $269,971
981 Added 6.39%
16,337 $3.95 Million
Q4 2022

Feb 06, 2023

BUY
$229.03 - $291.01 $99,169 - $126,007
433 Added 2.9%
15,356 $4.03 Million
Q3 2022

Nov 14, 2022

BUY
$224.46 - $253.15 $467,774 - $527,564
2,084 Added 16.23%
14,923 $3.36 Million
Q2 2022

Aug 08, 2022

BUY
$230.71 - $256.74 $207,408 - $230,809
899 Added 7.53%
12,839 $3.12 Million
Q1 2022

May 12, 2022

BUY
$219.27 - $242.57 $252,160 - $278,955
1,150 Added 10.66%
11,940 $2.89 Million
Q4 2021

Feb 02, 2022

SELL
$198.88 - $227.6 $301,502 - $345,041
-1,516 Reduced 12.32%
10,790 $2.43 Million
Q3 2021

Nov 12, 2021

SELL
$212.27 - $248.7 $1.74 Million - $2.04 Million
-8,220 Reduced 40.05%
12,306 $2.62 Million
Q2 2021

Aug 03, 2021

BUY
$233.58 - $259.14 $180,557 - $200,315
773 Added 3.91%
20,526 $5 Million
Q1 2021

May 17, 2021

BUY
$221.91 - $258.6 $408,758 - $476,341
1,842 Added 10.28%
19,753 $4.92 Million
Q4 2020

Feb 11, 2021

SELL
$216.38 - $257.67 $5.74 Million - $6.84 Million
-26,531 Reduced 59.7%
17,911 $4.12 Million
Q3 2020

Nov 13, 2020

SELL
$234.65 - $260.95 $560,578 - $623,409
-2,389 Reduced 5.1%
44,442 $11.3 Million
Q2 2020

Aug 11, 2020

BUY
$197.81 - $242.74 $69,233 - $84,959
350 Added 0.75%
46,831 $11 Million
Q1 2020

May 08, 2020

BUY
$182.24 - $241.7 $2.24 Million - $2.97 Million
12,278 Added 35.9%
46,481 $9.42 Million
Q4 2019

Feb 07, 2020

BUY
$189.21 - $243.2 $110,687 - $142,272
585 Added 1.74%
34,203 $8.25 Million
Q3 2019

Oct 31, 2019

SELL
$174.11 - $208.62 $124,314 - $148,954
-714 Reduced 2.08%
33,618 $6.51 Million
Q2 2019

Aug 09, 2019

SELL
$166.7 - $195.41 $1.45 Million - $1.7 Million
-8,704 Reduced 20.22%
34,332 $6.33 Million
Q1 2019

Apr 24, 2019

SELL
$180.87 - $203.88 $136,556 - $153,929
-755 Reduced 1.72%
43,036 $8.18 Million
Q4 2018

Jan 30, 2019

BUY
$178.4 - $208.25 $561,960 - $655,987
3,150 Added 7.75%
43,791 $8.53 Million
Q3 2018

Oct 26, 2018

SELL
$185.29 - $208.89 $123,217 - $138,911
-665 Reduced 1.61%
40,641 $8.42 Million
Q2 2018

Aug 10, 2018

BUY
$166.05 - $186.51 $107,102 - $120,298
645 Added 1.59%
41,306 $7.63 Million
Q1 2018

May 09, 2018

BUY
$169.43 - $198.0 $380,539 - $444,708
2,246 Added 5.85%
40,661 $6.93 Million
Q3 2017

Nov 14, 2017

BUY
$167.29 - $191.0 $6.43 Million - $7.34 Million
38,415
38,415 $7.16 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $171B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Oppenheimer Asset Management Inc. Portfolio

Follow Oppenheimer Asset Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer Asset Management Inc. with notifications on news.